CYP2C8 and APOE

Number of citations of the paper that reports this interaction (PMID 21163940)
13

Data Source:
BioGRID (two hybrid)

		CYP2C8	APOE
Gene Name		cytochrome P450, family 2, subfamily C, polypeptide 8	apolipoprotein E
Image
Gene Ontology Annotations	Cellular Component	Cytoplasm Endoplasmic Reticulum Membrane Intracellular Membrane-bounded Organelle	Extracellular Region Extracellular Space Nucleus Nuclear Envelope Cytoplasm Lysosome Early Endosome Late Endosome Endoplasmic Reticulum Golgi Apparatus Microtubule Plasma Membrane Membrane Dendrite Extracellular Matrix Extrinsic Component Of External Side Of Plasma Membrane Vesicle Very-low-density Lipoprotein Particle Low-density Lipoprotein Particle Intermediate-density Lipoprotein Particle High-density Lipoprotein Particle Discoidal High-density Lipoprotein Particle Chylomicron Neuronal Cell Body Extracellular Vesicular Exosome Endocytic Vesicle Lumen Blood Microparticle
	Molecular Function	Monooxygenase Activity Iron Ion Binding Arachidonic Acid Epoxygenase Activity Steroid Hydroxylase Activity Oxidoreductase Activity, Acting On Paired Donors, With Incorporation Or Reduction Of Molecular Oxygen, Reduced Flavin Or Flavoprotein As One Donor, And Incorporation Of One Atom Of Oxygen Oxygen Binding Heme Binding Caffeine Oxidase Activity Aromatase Activity	Beta-amyloid Binding Lipid Transporter Activity Protein Binding Phospholipid Binding Heparin Binding Lipid Binding Cholesterol Binding Antioxidant Activity Cholesterol Transporter Activity Identical Protein Binding Protein Homodimerization Activity Hydroxyapatite Binding Metal Chelating Activity Tau Protein Binding Low-density Lipoprotein Particle Receptor Binding Phosphatidylcholine-sterol O-acyltransferase Activator Activity Very-low-density Lipoprotein Particle Receptor Binding Lipoprotein Particle Binding
	Biological Process	Organic Acid Metabolic Process Xenobiotic Metabolic Process Drug Metabolic Process Arachidonic Acid Metabolic Process Epoxygenase P450 Pathway Exogenous Drug Catabolic Process Small Molecule Metabolic Process Oxidation-reduction Process Oxidative Demethylation Omega-hydroxylase P450 Pathway	Response To Reactive Oxygen Species Retinoid Metabolic Process Negative Regulation Of Endothelial Cell Proliferation Response To Dietary Excess Triglyceride Metabolic Process Cholesterol Catabolic Process Cellular Calcium Ion Homeostasis Receptor-mediated Endocytosis Cytoskeleton Organization G-protein Coupled Receptor Signaling Pathway Nitric Oxide Mediated Signal Transduction Synaptic Transmission, Cholinergic Aging Phototransduction, Visible Light Cholesterol Metabolic Process Regulation Of Gene Expression Negative Regulation Of Platelet Activation Positive Regulation Of Cholesterol Esterification Positive Regulation Of Cholesterol Efflux Peripheral Nervous System Axon Regeneration Long-chain Fatty Acid Transport Protein Import Triglyceride Catabolic Process CGMP-mediated Signaling Negative Regulation Of Blood Coagulation Regulation Of Axon Extension Positive Regulation Of CGMP Biosynthetic Process Neuron Projection Regeneration Regulation Of Cdc42 Protein Signal Transduction Response To Retinoic Acid Positive Regulation Of Low-density Lipoprotein Particle Receptor Catabolic Process Response To Insulin Cholesterol Efflux Phospholipid Efflux Very-low-density Lipoprotein Particle Remodeling Low-density Lipoprotein Particle Remodeling High-density Lipoprotein Particle Remodeling High-density Lipoprotein Particle Assembly Chylomicron Remnant Clearance High-density Lipoprotein Particle Clearance Very-low-density Lipoprotein Particle Clearance Lipoprotein Metabolic Process Lipoprotein Biosynthetic Process Lipoprotein Catabolic Process Vasodilation Cholesterol Homeostasis Negative Regulation Of MAP Kinase Activity Negative Regulation Of Neuron Apoptotic Process Negative Regulation Of Blood Vessel Endothelial Cell Migration Reverse Cholesterol Transport Small Molecule Metabolic Process Response To Ethanol Negative Regulation Of Cholesterol Biosynthetic Process Positive Regulation Of Axon Extension Positive Regulation Of Lipid Biosynthetic Process Intracellular Transport Regulation Of Neuronal Synaptic Plasticity Oligodendrocyte Differentiation Artery Morphogenesis Negative Regulation Of Inflammatory Response Positive Regulation Of Nitric-oxide Synthase Activity Positive Regulation Of Membrane Protein Ectodomain Proteolysis Negative Regulation Of Lipid Biosynthetic Process Maintenance Of Location In Cell Fatty Acid Homeostasis Positive Regulation Of Dendritic Spine Development Negative Regulation Of Dendritic Spine Development Cellular Response To Interleukin-1 Cellular Response To Growth Factor Stimulus Cellular Response To Cholesterol Negative Regulation Of Cholesterol Efflux Alpha-amino-3-hydroxy-5-methyl-4-isoxazole Propionate Selective Glutamate Receptor Clustering N-methyl-D-aspartate Receptor Clustering Regulation Of Beta-amyloid Clearance Regulation Of Neuron Death Negative Regulation Of Neuron Death Positive Regulation Of Neuron Death Negative Regulation Of Postsynaptic Membrane Organization Positive Regulation Of Postsynaptic Membrane Organization Negative Regulation Of Presynaptic Membrane Organization Positive Regulation Of Presynaptic Membrane Organization Positive Regulation Of Beta-amyloid Formation Negative Regulation Of Beta-amyloid Formation Regulation Of Tau-protein Kinase Activity Negative Regulation Of Dendritic Spine Maintenance Positive Regulation Of Dendritic Spine Maintenance Positive Regulation Of Phospholipid Efflux Positive Regulation Of Neurofibrillary Tangle Assembly Negative Regulation Of Phospholipid Efflux Negative Regulation Of Lipid Transport Across Blood Brain Barrier Positive Regulation Of Lipid Transport Across Blood Brain Barrier
Pathways		Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B) Metabolism of lipids and lipoproteins Metabolic disorders of biological oxidation enzymes Phase 1 - Functionalization of compounds Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A) Arachidonic acid metabolism Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4) Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56) Cytochrome P450 - arranged by substrate type CYP2E1 reactions Biological oxidations Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD) Defective FMO3 causes Trimethylaminuria (TMAU) Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX) Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4) Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA) Defective CYP1B1 causes Glaucoma Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5) Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3) Defective CYP19A1 causes Aromatase excess syndrome (AEXS) Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5) Defective CYP24A1 causes Hypercalcemia, infantile (HCAI) Xenobiotics Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) Defective MAOA causes Brunner syndrome (BRUNS) Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency) Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)	Lipoprotein metabolism Metabolism of lipids and lipoproteins Chylomicron-mediated lipid transport Lipid digestion, mobilization, and transport Diseases associated with visual transduction HDL-mediated lipid transport Visual phototransduction Scavenging by Class A Receptors Retinoid metabolism and transport
Drugs			Human Serum Albumin Serum albumin iodonated
Diseases
GWAS		Immune response to smallpox vaccine (IL-6) ( 22542470) Osteonecrosis of the jaw ( 18594024) Response to clopidogrel therapy ( 19706858) Warfarin maintenance dose ( 23755828)	Age-related macular degeneration ( 23326517 23455636) Alzheimer's disease ( 17975299 22832961 20460622 17998437 18823527 19734902 19734903 21627779 19125160 20061627 22245343) Alzheimer's disease (age of onset) ( 22005931) Alzheimer's disease (late onset) ( 17474819 20885792 23565137) Alzheimer's disease biomarkers ( 23562540 21123754 23419831) Apolipoprotein Levels ( 23031429) Brain imaging ( 20100581) C-reactive protein ( 19567438 18439548 18439552) Cardiovascular disease risk factors ( 20838585) Cholesterol, total ( 19060911 20686565) Cognitive decline ( 22054870) HDL cholesterol ( 21909109 19060911 20686565) Hippocampal atrophy ( 22745009) LDL cholesterol ( 23726366 18802019 18193043 18193044 20864672 19060906 19060911 23067351 20686565) Lipid metabolism phenotypes ( 22286219) Lipoprotein-associated phospholipase A2 activity and mass ( 23118302) Longevity ( 21418511) Metabolic syndrome ( 22399527) Metabolite levels ( 22916037) Quantitative traits ( 19197348) Response to statin therapy (LDL-C) ( 22331829) Triglycerides ( 19060911 20686565)
Protein-Protein Interactions		11 interactors: A2M APOE BLMH DNAJB1 ECSIT EXOC6 IFIT3 LONP1 MAST1 PSEN1 RNF32	54 interactors: A2M ACTG1 ALB ANKH APP ARFGAP1 C19orf52 CDC37 CNTF CSNK2A1 CTSB CYP2C18 CYP2C8 ECSIT ELAVL1 EPN2 FARSA FBXL12 FOXG1 FXYD7 GCDH HTRA1 IFIT3 IFIT5 IQSEC1 LCAT LDLR LONP1 LOXL4 LRP1 LRP2 LRP8 MAP2 MAPT MAST1 MID1IP1 NEFM NOS3 PCMT1 PDCD4 PLEKHA6 PLTP PRAM1 PRDX2 PRNP PSEN1 RHEB RNF32 RPL4 SCARB1 ST13 TYRO3 VLDLR ZNF558
Entrez ID		1558	348
HPRD ID		03083	00135
Ensembl ID		ENSG00000138115	ENSG00000130203
Uniprot IDs		B7Z1F5 P10632	P02649
PDB IDs		1PQ2 2NNH 2NNI 2NNJ 2VN0	1B68 1BZ4 1EA8 1GS9 1H7I 1LE2 1LE4 1LPE 1NFN 1NFO 1OEF 1OEG 1OR2 1OR3 2KC3 2KNY 2L7B
Enriched GO Terms of Interacting Partners?		Regulation Of Inclusion Body Assembly Response To Stress Protein Metabolic Process Exocytosis Oxidation-dependent Protein Catabolic Process Cajal-Retzius Cell Differentiation Positive Regulation Of Low-density Lipoprotein Particle Receptor Catabolic Process Positive Regulation Of Dendritic Spine Maintenance Negative Regulation Of Dendritic Spine Maintenance Negative Regulation Of Phospholipid Efflux Negative Regulation Of Lipid Transport Across Blood Brain Barrier Positive Regulation Of Lipid Transport Across Blood Brain Barrier Beta-amyloid Formation Positive Regulation Of Postsynaptic Membrane Organization Negative Regulation Of Postsynaptic Membrane Organization Regulation Of Oxidoreductase Activity Response To Stimulus Response To Oxidative Stress Regulation Of Cellular Component Organization Extracellular Matrix Disassembly Establishment Of Localization In Cell Positive Regulation Of Neurofibrillary Tangle Assembly Smooth Endoplasmic Reticulum Calcium Ion Homeostasis Negative Regulation Of Complement Activation, Lectin Pathway Negative Regulation Of Presynaptic Membrane Organization Positive Regulation Of Presynaptic Membrane Organization Cellular Response To Stimulus Secretion By Cell Immune System Process Negative Regulation Of Neuron Projection Development Positive Regulation Of Phospholipid Efflux Negative Regulation Of Cholesterol Biosynthetic Process Regulation Of Mitochondrial DNA Replication Regulation Of Postsynaptic Membrane Organization Very-low-density Lipoprotein Particle Clearance Negative Regulation Of Cell Projection Organization Regulation Of Catalytic Activity Synaptic Vesicle Targeting Regulation Of Resting Membrane Potential Cellular Localization Positive Regulation Of Cellular Protein Catabolic Process Maintenance Of Location In Cell Regulation Of Axonogenesis Secretion Regulation Of Low-density Lipoprotein Particle Receptor Catabolic Process Regulation Of Tau-protein Kinase Activity Response To Aluminum Ion Negative Regulation Of Cholesterol Efflux N-methyl-D-aspartate Receptor Clustering Regulation Of Presynaptic Membrane Organization	Endocytosis Steroid Metabolic Process Vesicle-mediated Transport Cholesterol Metabolic Process Lipid Metabolic Process Sterol Metabolic Process Receptor-mediated Endocytosis Developmental Process Response To External Stimulus Smooth Endoplasmic Reticulum Calcium Ion Homeostasis Alcohol Metabolic Process Locomotion Movement Of Cell Or Subcellular Component Regulation Of Plasma Lipoprotein Particle Levels Regulation Of Catalytic Activity Negative Regulation Of Apoptotic Process Cholesterol Import Regulation Of Phosphatidylcholine Catabolic Process Negative Regulation Of Programmed Cell Death Anatomical Structure Morphogenesis Cellular Response To Stimulus Multicellular Organismal Development Phototransduction, Visible Light Blood Coagulation Retinoid Metabolic Process Negative Regulation Of Cell Death Hemostasis Regulation Of Cellular Protein Metabolic Process Wound Healing Negative Regulation Of Neuron Apoptotic Process Lipoprotein Metabolic Process System Development Diterpenoid Metabolic Process Regulation Of Phosphorus Metabolic Process Anatomical Structure Development Lipid Transport Detection Of Visible Light Nervous System Development Apoptotic Cell Clearance Transport Phototransduction Small Molecule Metabolic Process Platelet Activation Lipid Localization Generation Of Neurons Plasma Lipoprotein Particle Clearance Negative Regulation Of Neuron Death Detection Of Light Stimulus Response To Wounding Reelin-mediated Signaling Pathway
Tagcloud ?		allele apolipoprotein associations cardiotoxicity commonly comt conform epsilon4 failed fatigue genetic genotype guidelines il6 impairment listed lle655val met neuropathy polymorphisms reporting strega systematic toxicities transparent underlying val variant variants	aa adenovirus agreement amyloid amyloids apoe3 apoe4 apoj apolipoprotein apolipoproteins appear cerebral characterize deficient define deposition deposits fibril fibrillogenesis fibrils fragment greatest heterozygous injected lacking lipoproteins promoting restored utilized
Tagcloud (Difference) ?		allele associations cardiotoxicity commonly comt conform epsilon4 failed fatigue genetic genotype guidelines il6 impairment listed lle655val met neuropathy polymorphisms reporting strega systematic toxicities transparent underlying val variant variants	aa adenovirus agreement amyloid amyloids apoe3 apoe4 apoj apolipoproteins appear cerebral characterize deficient define deposition deposits fibril fibrillogenesis fibrils fragment greatest heterozygous injected lacking lipoproteins promoting restored utilized
Tagcloud (Intersection) ?		apolipoprotein